Related Experiment Video
Updated: Aug 13, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.6K
A Comprehensive Exploration of the Transcriptomic Landscape in Multiple Sclerosis: A Systematic Review
Luigi Chiricosta1, Santino Blando1, Simone D'Angiolini1
1IRCCS Centro Neurolesi "Bonino-Pulejo", Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
International Journal of Molecular Sciences
|January 21, 2023
Summary
Transcriptomic profiling reveals distinct molecular signatures in Multiple Sclerosis (MS) at different stages. Non-coding RNAs and altered gene expression, particularly neddylation, are implicated in MS pathogenesis and sex-dependent effects.
Area of Science:
- Neuroscience
- Genomics
- Molecular Biology
Background:
- Multiple Sclerosis (MS) is a chronic, incurable neurological disorder characterized by demyelination.
- While genetic mutations are linked to MS, they don't explain all cases, suggesting a role for altered gene expression.
Approach:
- This review focuses on RNA-sequencing (RNA-seq) methods, including bulk and single-cell approaches, for analyzing transcriptomic profiles in MS.
- RNA-seq is rapidly replacing microarrays due to its ability to generate vast amounts of data.
Key Points:
- Distinct molecular signatures characterize different stages of MS.
- Non-coding RNAs are identified as potentially crucial players in MS.
- Sex-dependence in biological processes and drug responses is observed in MS.
- New deregulated pathways, such as neddylation, are identified in MS.
- Spatial transcriptomics links inflammation to neurodegeneration in MS.
Conclusions:
- Transcriptomic analysis using RNA-seq is a powerful strategy for uncovering novel mechanisms in complex diseases like MS.
- Understanding altered gene expression and pathways offers new avenues for MS research and potential therapeutic targets.

